It has been also reported that PAX2 is activated by E2 via ERα in breast cancer and it is confirmed that the expression of PAX2 is proportional to the expression of ERα in ovarian serous cancer [79]. The gene discussed is ESR1; the disease is ovarian serous adenocarcinoma.